CEA Industries (BNC) Proxy Filing summary
Event summary combining transcript, slides, and related documents.
Proxy Filing summary
4 Feb, 2026Executive summary
Board seeks to renegotiate the Asset Management Agreement (AMA) with 10X Capital to improve terms, including fees, term, and termination provisions.
A previously undisclosed side agreement between 10X Capital and YZi Labs diverted fees and restricted renegotiation of the AMA.
Board requests confirmation from both 10X and YZi Labs that the side agreement is terminated to enable AMA renegotiation.
10X Capital has indicated willingness to terminate the side agreement and renegotiate the AMA, potentially reducing management fees.
Forward-looking statements highlight risks and uncertainties regarding the outcome of AMA renegotiation and future fee reductions.
Voting matters and shareholder proposals
Company will file a consent revocation statement and a YELLOW consent revocation card in response to YZi Labs' consent solicitation.
Stockholders are encouraged to review all related materials when available for important information.
Board of directors and corporate governance
Board members include Anthony K. McDonald, Nicholas J. Etten, Carly E. Howard, Hans Thomas, and Annemarie Tierney.
Executive officer David Namdar is also a participant in the consent revocation solicitation.
Information on directors, officers, and their interests is available in recent SEC filings, including Form 10-KT and Form 8-K.
Latest events from CEA Industries
- Strategic shift to a BNB digital asset treasury, leveraging a clean balance sheet and warrant capital.BNC
Water Tower Research Insights Conference14 Apr 2026 - Board seeks better asset management terms and urges stockholder action on consent revocation.BNC
Proxy filing26 Mar 2026 - Board seeks to amend asset management terms with 10X; shareholder action on YZi Labs' solicitation urged.BNC
Proxy filing26 Mar 2026 - Board rejects YZi Labs' consent solicitation for non-compliance with disclosure requirements.BNC
Proxy filing24 Mar 2026 - Board denies YZi Labs' consent solicitation request for lack of required disclosures.BNC
Proxy filing24 Mar 2026 - Q3 net loss of $106.6M due to BNB decline, with CEO transition and share buybacks announced.BNC
Q3 202616 Mar 2026 - Board reviews YZi Labs' consent solicitation; stockholders to await further SEC filings.BNC
Proxy Filing16 Mar 2026 - Board reviews YZi Labs' bid to expand and control Board; stockholders await further guidance.BNC
Proxy Filing16 Mar 2026 - Disciplined BNB treasury strategy, clean balance sheet, and active shareholder engagement.BNC
Proxy Filing25 Feb 2026 - Shareholders to vote amid calls for full disclosure of a secret side agreement.BNC
Proxy Filing25 Feb 2026